Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination

Brain Pathology

Volumn 17, Issue 2, 2007, Pages 184-196

  Pavelko, Kevin D ^a   Pease, Larry R ^a   David, Chella S ^a   Rodriguez, Moses ^a,b  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PROTEIN VP2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE PREDISPOSITION; GENE DELETION; GENE EXPRESSION; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; PATHOLOGY; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE; VIRUS; VIRUS CAPSID; WHITE MATTER;

ANIMALS; BLOTTING, WESTERN; BRAIN; CAPSID PROTEINS; DEMYELINATING DISEASES; FLOW CYTOMETRY; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOHISTOCHEMISTRY; MICE; MICE, TRANSGENIC; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPINAL CORD; T-LYMPHOCYTES; THEILOVIRUS;

EID: 33947510838     PISSN: 10156305     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2007.00062.x     Document Type: Article

References (45)

1. Baldwin TA, Hogquist KA, Jameson SC (2004) The fourth way? Harnessing aggressive tendencies in the thymus. J Immunol 173:6515-6520.
2. Bielekova B, Goodwin B, Richert N, Cortese I, Kondo T, Afshar G, Gran B, Eaton J, Antel J, Frank JA, McFarland HF, Martin R (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat Med 6:1167-1175.
3. Borson ND, Paul C, Lin X, Nevala WK, Strausbauch MA, Rodriguez M, Wettstein PJ (1997) Brain-infiltrating cytolytic T lymphocytes specific for Theiler's virus recognize H2Db molecules complexed with a viral VP2 peptide lacking a consensus anchor residue. J Virol 71:5244-5250.
4. Clatch RJ, Pevear DC, Rozhon E, Roos RP, Miller SD, Lipton HL (1987) Characterization and specificity of humoral immune responses to Theiler's murine encephalomyelitis virus capsid proteins. J Gen Virol 68(Pt 12):3191-3196.
5. Critchfield JM, Racke MK, Zuniga-Pflucker JC, Cannella B, Raine CS, Goverman J, Lenardo MJ (1994) T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. Science 263:1139-1143.
6. Disis ML, Salazar LG, Knutson KL (2004) Peptide-based vaccines in breast cancer. Breast Dis 20:3-11.
7. Drescher KM, Murray PD, David CS, Pease LR, Rodriguez M (1999) CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol 9:21-31.
8. Ferguson TA, Stuart PM, Herndon JM, Griffith TS (2003) Apoptosis, tolerance, and regulatory T cells-old wine, new wineskins. Immunol Rev 193:111-123.
9. Gerety SJ, Rundell MK, Dal Canto MC, Miller SD (1994) Class II-restricted T cell responses in Theiler's murine encephalomyelitis virus-induced demyelinating disease. VI. Potentiation of demyelination with and characterization of an immunopathologic CD4+ T cell line specific for an immunodominant VP2 epitope. J Immunol 152:919-929.
10. Hogquist KA, Baldwin TA, Jameson SC (2005) Central tolerance: learning self-control in the thymus. Nat Rev Immunol 5:772-782.
11. Inoue A, Choe YK, Kim BS (1994) Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol 68:3324-3333.
12. Johnson AJ, Njenga MK, Hansen MJ, Kuhns ST, Chen L, Rodriguez M, Pease LR (1999) Prevalent class I-restricted T-cell response to the Theiler's virus epitope Db:vP2121-130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. J Virol 73:3702-3708.
13. Johnson AJ, Mendez-Fernandez Y, Moyer AM, Sloma CR, Pirko I, Block MS, Rodriguez M, Pease LR (2005) Antigen-specific CD8+ T cells mediate a peptide-induced fatal syndrome. J Immunol 174:6854-6862.
14. Kang B, Kang HK, Kim BS (2005) Identification of capsid epitopes of Theiler's virus recognized by CNS-infiltrating CD4+ T cells from virus-infected C57BL/6 mice. Virus Res 108:57-61.
15. Kappos L, Comi G, Panitch H, Oger J, Antel J, Conlon P, Steinman L (2000) Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group. Nat Med 6:1176-1182.
16. Lin X, Njenga MK, Johnson AJ, Pavelko KD, David CS, Pease LR, Rodriguez M (2002) Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination. J Virol 76:7799-7811.
17. Lindsley MD, Thiemann R, Rodriguez M (1991) Cytotoxic T cells isolated from the central nervous systems of mice infected with Theiler's virus. J Virol 65:6612-6620.
18. Lohr J, Knoechel B, Nagabhushanam V, Abbas AK (2005) T-cell tolerance and autoimmunity to systemic and tissue-restricted self-antigens. Immunol Rev 204:116-117.
19. McDevitt H (2004) Specific antigen vaccination to treat autoimmune disease. Proc Natl Acad Sci USA 101(Suppl.2):14627-14630.
20. Mendez-Fernandez YV, Johnson AJ, Rodriguez M, Pease LR (2003) Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur J Immunol 33:2501-2510.
21. Miller SD, Vanderlugt CL, Begolka WS, Pao W, Yauch RL, Neville KL, Katz-Levy Y, Carrizosa A, Kim BS (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med 3:1133-1136.
22. Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M (1998) CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol 72:7320-7329.
23. Njenga MK, Pavelko KD, Baisch J, Lin X, David C, Leibowitz J, Rodriguez M (1996) Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J Virol 70:1729-1737.
24. Ohara Y, Stein S, Fu JL, Stillman L, Klaman L, Roos RP (1988) Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164:245-255.
25. Oldstone MB, Nerenberg M, Southern P, Price J, Lewicki H (1991) Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319-331.
26. Pavelko KD, Howe CL, Drescher KM, Gamez JD, Johnson AJ, Wei T, Ransohoff RM, Rodriguez M (2003) Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci 23:481-492.
27. Pedotti R, Sanna M, Tsai M, DeVoss J, Steinman L, McDevitt H, Galli SJ (2003) Severe anaphylactic reactions to glutamic acid decarboxylase (GAD) self peptides in NOD mice that spontaneously develop autoimmune type 1 diabetes mellitus. BMC Immunol 4:2.
28. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, Amox D, Roord S, de Kleer I, Bonnin D, Lanza P, Berry C, Massa M, Billetta R, Albani S (2004) Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA 101:4228-4233.
29. Rodriguez M, Leibowitz J, David CS (1986) Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J Exp Med 163:620-631.
30. Rodriguez M, Oleszak E, Leibowitz J (1987) Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol 7:325-365.
31. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, Nakane S, Papke LM (2003) Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J Virol 77:12252-12265.
32. Rosenthal A, Fujinami RS, Lampert PW (1986) Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest 54:515-522.
33. Schorpp M, Jager R, Schellander K, Schenkel J, Wagner EF, Weiher H, Angel P (1996) The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice. Nucleic Acids Res 24:1787-1788.
34. Sela M, Mozes E (2004) Therapeutic vaccines in autoimmunity. Proc Natl Acad Sci USA 101(Suppl.2):14586-14592.
35. Starr TK, Jameson SC, Hogquist KA (2003) Positive and negative selection of T cells. Annu Rev Immunol 21:139-176.
36. Szomolanyi-Tsuda E, Welsh RM (1998) T-cell-independent antiviral antibody responses. Curr Opin Immunol 10:431-435.
37. Tsunoda I, Kuang LQ, Kobayashi-Warren M, Fujinami RS (2005) Central nervous system pathology caused by autoreactive CD8+ T-cell clones following virus infection. J Virol 79:14640-14646.
38. Verhoef A, Alexander C, Kay AB, Larche M (2005) T cell epitope immunotherapy induces a CD4+ T cell population with regulatory activity. PLoS Med 2:e78.
39. von Herrath MG, Harrison LC (2003) Antigen-induced regulatory T cells in autoimmunity. Nat Rev Immunol 3:223-232.
40. von Herrath MG, Dockter J, Nerenberg M, Gairin JE, Oldstone MB (1994) Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus. J Exp Med 180:1901-1910.
41. Walker LS, Abbas AK (2002) The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2:11-19.
42. Yauch RL, Kim BS (1994) A predominant viral epitope recognized by T cells from the periphery and demyelinating lesions of SJL/J mice infected with Theiler's virus is located within VP1 (233-244). J Immunol 153:4508-4519.
43. Yauch RL, Kerekes K, Saujani K, Kim BS (1995) Identification of a major T-cell epitope within VP3 amino acid residues 24 to 37 of Theiler's virus in demyelination-susceptible SJL/J mice. J Virol 69:7315-7318.
44. Yauch RL, Palma JP, Yahikozawa H, Koh CS, Kim BS (1998) Role of individual T-cell epitopes of Theiler's virus in the pathogenesis of demyelination correlates with the ability to induce a Th1 response. J Virol 72:6169-6174.
45. Yewdell JW, Anton LC, Bennink JR (1996) Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules? J Immunol 157:1823-1826.